|Bid||0.00 x 1100|
|Ask||0.00 x 1400|
|Day's Range||26.12 - 27.75|
|52 Week Range||20.05 - 30.71|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.67|
Investors are always looking for growth in small-cap stocks like Establishment Labs Holdings Inc. (NASDAQ:ESTA), with a market cap of US$524m. However, an important fact which most ignore is: how Read More...
NEW YORK, Nov. 13, 2018 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially.
Establishment Labs Holdings Inc. (ESTA) today announced that the Company will release its third quarter 2018 financial results on Tuesday, November 13, 2018, prior to the open of U.S. financial markets. Establishment Labs will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, November 13, 2018 to discuss its financial results. The dial-in number to access the call is U.S./Canada (877) 376-9925, International (629) 228-0732, and the conference ID is 5096498.
Establishment Labs Holdings Inc (NASDAQ:ESTA), a US$486m small-cap, operates in the healthcare industry, which faces more complex and interdependent challenges, requiring multi-pronged, collaborative, and technology-enabled business models. Healthcare analysts are Read More...